Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes

  • Robert S. Busch
    Albany Medical Center Division of Community Endocrinology, Albany, NY, USA
  • Michael P. Kane
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA

Journal

Citations (3)*help

See more

Details 詳細情報について

Report a problem

Back to top